M
The startup develops micro-engineered physiological systems that replicate organ-level functions using connected human tissues, providing a more accurate alternative to traditional 2D cell culture for biological research. This technology enables researchers to validate new biological mechanisms in a physiologically relevant environment, enhancing the drug discovery process.
Seoul, South Korea
Updated 2 months ago
Funding
$10.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops micro-engineered physiological systems that replicate organ-level functions using connected human tissues, providing a more accurate alternative to traditional 2D cell culture for biological research. This technology enables researchers to validate new biological mechanisms in a physiologically relevant environment, enhancing the drug discovery process.